A5HZZ5 (A5HZZ5_CLOBH) Clostridium botulinum (strain Hall / ATCC 3502 / NCTC 13319 / Type A)
Hemagglutinin component of the neurotoxin complex UniProtKBAFDB90v4InterProInteractive Modelling
146 aa; Sequence (Fasta) ;
3 identical sequences: Clostridium botulinum: A0A3F2ZS81, Q45878; Clostridium botulinum CFSAN001627: M1ZNV3
It is possible new templates exist for this target since these models were created.
Available Structures
9 Experimental Structures
Description | PDB ID | Oligo-state | Range | Ligands | ||
---|---|---|---|---|---|---|
Apo HA17-HA33 |
Heteromer Q45871; Q45878; | |||||
Assess | ||||||
Crystal structure of HA17-HA33-IPT |
Heteromer Q45871; Q45878; | 2×IPT; | ||||
Assess | ||||||
HA17-HA33-LacNac |
Heteromer Q45871; Q45878; | 2×NDG; | ||||
Assess | ||||||
HA17-HA33-Lac |
Heteromer Q45871; Q45878; | 2×BGC; | ||||
Assess | ||||||
HA17-HA33-Gal |
Heteromer Q45871; Q45878; | 2×GAL; | ||||
Assess | ||||||
Crystal structure of HA17-HA33-Lactulose |
Heteromer Q45871; Q45878; | 2×FRU; | ||||
Assess | ||||||
Molecular basis for disruption of E-cadherin adhesion by botulinum neurotoxin A complex |
Heteromer A5HZZ4; A5HZZ6; P09803; | 3×CA; | ||||
Assess | ||||||
HA70(D3)-HA17 |
Heteromer Q45878; Q8KHU9; | |||||
Assess | ||||||
HA70(D3)-HA17-HA33 |
Heteromer Q45871; Q45878; Q8KHU9; | |||||
Assess |
2 SWISS-MODEL models
Template | Oligo-state | QMEANDisCo | Range | Ligands | Trg-Tpl Seq id (%) | |
---|---|---|---|---|---|---|
4qd2.2.B | monomer | 0.90 | 100.00 | |||
Assess | ||||||
1ybi.2.A | monomer | 0.51 | 26.23 | |||
Assess |